Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
78.17%
operating margin TTM
-59.12%
revenue TTM
42.54 Million
revenue per share TTM
0.72$
valuation ratios | |
|---|---|
| pe ratio | 6.47 |
| peg ratio | 0.05 |
| price to book ratio | 3.48 |
| price to sales ratio | 5.37 |
| enterprise value multiple | 5.78 |
| price fair value | 3.48 |
profitability ratios | |
|---|---|
| gross profit margin | 84.22% |
| operating profit margin | -59.12% |
| pretax profit margin | 81.41% |
| net profit margin | 78.17% |
| return on assets | 29.23% |
| return on equity | 74.63% |
| return on capital employed | -25.64% |
liquidity ratios | |
|---|---|
| current ratio | 5.68 |
| quick ratio | 5.63 |
| cash ratio | 1.59 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 37.81 |
| operating cycle | 117.54 |
| days of payables outstanding | 53.85 |
| cash conversion cycle | 63.70 |
| receivables turnover | 4.58 |
| payables turnover | 6.78 |
| inventory turnover | 9.65 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.22 |
| debt equity ratio | 0.41 |
| long term debt to capitalization | 0.29 |
| total debt to capitalization | 0.29 |
| interest coverage | -7.89 |
| cash flow to debt ratio | -0.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.04 |
| cash per share | 3.45 |
| operating cash flow per share | -0.03 |
| free cash flow operating cash flow ratio | 1.52 |
| cash flow coverage ratios | -0.03 |
| short term coverage ratios | -3.81 |
| capital expenditure coverage ratio | -1.91 |
Frequently Asked Questions
When was the last time Zevra Therapeutics, Inc. (NASDAQ:ZVRA) reported earnings?
Zevra Therapeutics, Inc. (ZVRA) published its most recent earnings results on 05-11-2025.
What is Zevra Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Zevra Therapeutics, Inc. (NASDAQ:ZVRA)'s trailing twelve months ROE is 74.63%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Zevra Therapeutics, Inc. (ZVRA) currently has a ROA of 29.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ZVRA's net profit margin stand at?
ZVRA reported a profit margin of 78.17% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ZVRA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.68 in the most recent quarter. The quick ratio stood at 5.63, with a Debt/Eq ratio of 0.41.